WIN Symposium 2012 in Personalised Cancer Medicine
28 - 29 Jun 2012
Paris, France
The WIN 2012 Symposium, to be held in Paris, June 28-29, 2012, will be the next in the successful series of annual meetings dedicated to personalized cancer medicine. The WIN Consortium was created to accelerate the pace and reduce the cost of translating effective cancer treatments to the bedside.
The main theme of the 2012 symposium will be Efficacy of biomarkers and personalized cancer therapeutics. This theme will be elaborated in various plenary sessions:
- Fundamental concepts and strategies to improve efficacy of therapeutics
- WIN Consortium – Global innovative clinical trials
- Biology-driven diagnostics and therapeutics
- Combinatorial biomarkers and efficacy of therapeutics
- Innovative targets and new drug discoveries
- Innovative therapeutics and clinical trials
- Systems biology and bioinformatics
Everyone working in the development or implementation of personalized cancer medicine worldwide:
- Oncologists
- Pathologists
- Basic researchers
- Translational research scientists
- Bioinformatics specialists
- Pharmaceutical industry
- Biotechnology companies
- Diagnostic companies
- Governmental agencies
- Contract research organizations
- Venture capitalists
- Patient advocacy organizations
For matters regarding the 4th WIN Symposium, please contact the Symposium Secretariat directly:
Congress by design
P.O. Box 77
3480 DB Harmelen
The Netherlands
Tel. +31 88 089 8101
Fax +31 88 089 8109
Email: win@congressbydesign.com
No items were found.
